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Abstract
The Vc-NhaD is an Na + /H + antiporter from Vibrio cholerae belonging to a new family of bacterial Na + /H + antiporters, the NhaD
family. In the present work we mutagenized five conserved Asp and Glu residues and one conserved Thr residue to Ala in order to identify
amino acids that are critical for the antiport activity. All mutations fall into two distinct groups: (i) four variants, Glu100Ala, Glu251Ala,
Glu342Ala, and Asp393Ala, did not abolish antiport activity but shifted the pH optimum to more alkaline pH, and (ii) variants Asp344Ala,
Asp344Asn, and Thr345Ala caused a complete loss of both Na + /H + and Li + /H + antiport activity whereas the Asp344Glu variant exhibited
reduced Na + /H + and Li + /H + antiport activity. This is the first mutational analysis of the antiporter of NhaD type and the first
demonstration of Thr residue being indispensable for Na + /H + antiport. We discuss the possible role of Asp344 and Thr345 in the functioning
of Vc-NhaD. D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Bacterial sodium proton antiporters are ubiquitous sec-
ondary ion transporters playing important roles in cellular
ion homeostasis. They expel toxic Na + and Li + ions from
the cytoplasm at the expense of the proton motive force
(pmf) generated by primary proton pumps, thereby linking
H + and Na + circulation across the membrane. These
proteins are key elements in bacterial membrane energetics,
pH homeostasis, and halotolerance (see Refs. [1–3] for
review). Enterobacteria typically have a pair of specific
Na + (Li + )/H + antiporters, NhaA [4] and NhaB [5]. The
biochemical properties of the NhaA and NhaB from Escher-
ichia coli have been extensively studied in the laboratory of
Dr. E. Padan [6–12]. Both proteins exchange more than one
proton per sodium ion [6–9]. The activity of Ec-NhaB is pH-
independent whereas that of Ec-NhaA increases dramatically
upon pH shift from 7.0 to 8.0 [8]. Functional NhaA forms
homooligomers (most probably, dimers) in the membrane of
E. coli [13].
Despite this large body of data, surprisingly little is
known about the molecular mechanism that tightly couples
cation and proton exchange in Na + /H + antiporters. Ec-
NhaA remains the only bacterial Na + /H + antiporter, which
has been the subject of a systematic mutational analysis to
identify amino acid residues involved in cation binding and
transfer. Three Asp residues, D133, D163, and D164,
located within TMS IV and TMS V of the Ec-NhaA, are
critical for antiporter activity, presumably providing ligand-
ing groups for transported alkali cations [14,15]. These
residues are conserved in the NhaA family, and in phylo-
genetically more distant antiporters from various yeast
species [16] including Schizosaccharomyces pombe, where
the residues are essential for function [17]. Therefore, while
intramembrane acidic residues in NhaA-like antiporters are
indispensable for the antiport activity [16], residues critical
for function in other groups of bacterial Na + /H + antiporters
remain unknown.
Recently, we cloned a new Na + /H + antiporter from
Vibrio cholerae, Vc-NhaD, [18] which is present in the V.
cholerae membrane in addition to NhaA and NhaB [18,21].
Six conserved polar residues of Vc-NhaD are identified in
this report and variants in these residues are constructed to
study their role in the cation–proton exchange.
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2. Materials and methods
2.1. Materials
All chemicals were from Fisher Scientific or Sigma
Chemical Co. Restriction nucleases were from Gibco-
BRL, MBI Fermentas or New England Biolabs. The Trans-
former Site-directed Mutagenesis Kit was purchased from
Clontech.
2.2. Bacterial strains and culture conditions
The Na + /H + antiporter-deficient (melBLid, DNhaB1,
camR, DNhaA1, kanR, DlacZY, thr1) strain of E. coli,
EP432 was kindly provided by Dr. E. Padan (Hebrew
University of Jerusalem, Israel). For routine cloning and
plasmid construction, DH5a (US Biochemical Corp.) was
used as host. The mutS E. coli BMH 71-18 (Clontech) was
used to propagate mutated double-stranded DNA. V. chol-
erae strain 0395-N1 was kindly donated by Dr. J. Mekala-
nos (Harvard Medical School). If not indicated otherwise,
cells were grown in modified L broth (LBK) in which NaCl
was replaced by KCl [6]. For growth experiments, LBK
medium was used in which the starting pH was adjusted
between 4.5 and 8.5 by the addition of sterile Hepes–HCl
(pH 4.5 to 7.0) or Tris–HCl (pH 7.7 to 8.5) to the final
concentration of 20 mM prior inoculation of cells. All media
were supplemented with 100 Ag/ml ampicillin. Cells were
inoculated at OD600 = 0.05 and grown aerobically at 37 jC
for 7 h. Resulting growth was measured as the optical
density of bacterial suspension at 600 nm and plotted as a
function of starting pH for the control (LBK without
additions), LBK supplemented with 0.3 M NaCl or LBK
supplemented with 0.1 M LiCl (Fig. 2).
2.3. Site-directed mutagenesis
Site-directed mutagenesis of residues Glu100, Glu251,
Glu342, Asp344, Thr345, and Asp393 of Vc-NhaD was per-
formed with the Transformer Site-directed Mutagenesis Kit
(Clontech) as recommended by the manufacturer. The
commercial ScaI/StuI trans oligo (Clontech) was used as a
selection primer to obtain all mutations. The mutagenic
oligonucleotide primers (described in Table 1) were
designed to create or remove specific restriction enzyme
sites (listed in Table 1). As a template for mutagenesis, the
plasmid pBLDL (pBluescript II KS+(Stratagene) containing
the nhaD gene together with the 300-bp-long 5V and 230-
bp-long 3V flanking sequences as a 1837-bp EcoRI–BamHI
insert) was used [18]. Mutated plasmid DNA was isolated
from selected transformant clones and digested by the
following enzymes to excise the minimal nhaD fragments
containing the target mutation. BclI and EcoRI were used to
obtain a 536-bp fragment with the E100A mutation. BclI
and NcoI were used to obtain a 558-bp fragment with the
E251A mutation. BamHI and NcoI were used to obtain a
723-bp fragment with E342A, D344N, D344A, T345A, and
D344E mutations. Mutated fragments were then used to
replace the respective sequences in the original (nonmu-
tated) pBLDL. Fidelity of all final mutated versions of nhaD
in pBLDL was verified by DNA sequencing.
2.4. Isolation of membrane vesicles and assay of Na+/H+
antiport activity
Inside-out membrane vesicles were obtained by passing
a bacterial suspension through a French press (Aminco) and
assayed for Na + /H + antiport activity as described previ-
ously [18,22]. Protein content in membrane vesicles was
determined by the Bio-Rad Detergent Compatible Protein
Assay Kit. The Na + /H + antiporter activity was registered
by the acridine orange fluorescence dequenching. Aliquots
of vesicles (300 Ag of protein) were resuspended in 2 ml of
a medium containing 100 mM KCl, 250 mM sucrose, 10
mM MgSO4, 0.5 AM acridine orange, and 50 mM Hepes–
Tris buffer adjusted to the indicated pH. Respiration-
dependent formation of the DpH was initiated by the
addition of 10 mM Tris–D-lactate, and the resulting quench-
ing of acridine orange fluorescence was monitored with the
Shimadzu RF-1501 spectrofluorophotometer (excitation at
Table I
Mutagenic primers used for site-directed mutagenesis in NhaD
Mutation Mutagenic primera Codon! change Restriction site added (+)
or removed ( )
E100A CTTGAATACGCAGCGCTGCTGCTGTTTTTATTGGTCGCC GAG!GCG +HhaI
E251A CCAGCATCCAAGAAGTGGTCGCGCTTAAACGCGA GAG!GCG +HhaI
E342A GCATTTCTCACGCCGCCTGGGACACTTTACTGTTTTTCTATGGGG GAA!GCC +EcoRII
D344N GCATTTCTCACGCCGAATGGAACACGTTACTGTTTTTCTATGGGG GAC!AAC +AflIII
D344A CGCCGAATGGGCCACTTTACTGTTTTTC GAC!GCC BsmFI
D344E CGCCGAATGGGAAACTTTACTGTTTTTC GAC!GAA BsmFI
D393N GGCTGCTTTCTTCGGTGGTCAACAACAATCCTGTC GAT!AAC +HincII
D393A CGGTGGTCGCGAACATTCCTGTC GAT!GCG +Bsp68I
D393E CGGTGGTCGAAAACATTCCTGTC GAT!GAA +XmnI
T345A GCCGAATGGGACGCTTTACTGTTTTTTC ACT!GCT +HgaI
a The mutated nucleotides are shown in boldface.
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492 nm and emission at 528 nm). Na + /H + antiporter
activity was estimated based on its ability to dissipate the
established DpH upon addition of indicated concentrations
of NaCl or LiCl (10 mM in the pH-profile determination;
0.5 to 20 mM for the determination of half-maximal
effective concentration). The antiport activities are
expressed as percent restoration of the lactate-induced
fluorescence quenching.
2.5. Addition of 6His tag to the C-terminus of Vc-NhaD
and N-terminal sequencing of tagged protein
To add the 6His tag to the C-terminus of Vc-NhaD, the
PCR reaction was carried out using pBLDL as a template.
The forward PCR primer was 5V-act aaa cat ATG ACG GGC
CGG ATC GCA CTA C-3V(adds NdeI restriction site, under-
lined), and the reverse PCR primer was 5V-att tga gtc gac
Fig. 1. Conserved polar residues in Vc-NhaD selected for mutagenesis. Panel A: Putative membrane topology of NhaD from V. cholerae and V.
parahaemolyticus. The model was constructed using the HMMTOP program [26]. Residues selected for mutagenesis in Vc-NhaD and their analogs in Vp-
NhaD are shown. Residues affecting the ion exchange in Vc-NhaD are given in italics. Panel B: Partial alignments of the derived amino acid sequence of NhaD
from V. cholerae and NhaD from V. parahaemolyticus. Alignments are shown for five negatively charged acidic residues (E100, E251, E342, D344, and D393)
whose topology is presumably conserved in both antiporters. Threonine at the position 296 is ‘‘topologically’’ conserved as well. Residues chosen for
mutagenesis are given in boldface; numbers preceding sequences indicate the number of the first amino acid.
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TGT GAA TGA TTG ATG ATT GAG C-3V(adds SalI site,
underlined). The PCR product was cloned into the pET22b+
vector (Novagen), yielding pETL construct. The C-terminal
part of the constructed (tagged) Vc-NhaD is: VDKLAAA-
LEHHHHHH. The pETL was digested with EspI, treated
with Klenow fragment to produce blunt ends, and digested
with StuI. The terminal portion of nhaD with added tag was
cloned into pBLDL digested with StuI and Ecl136I, yielding
plasmid pBDH, which contained nhaD–6His down-
stream of its natural promoter. Validity of the resulting
pBDH construct was confirmed by sequencing.
EP432 cells were electroporated with pBDH, and mem-
brane vesicles were isolated as described above from 4 l of
late-logarithmic culture grown on LBK supplemented with
0.1 M LiCl. Isolated membranes were washed once and
resuspended in 3 ml of Buffer A containing 60 mM
choline–Cl, 100 mM sucrose, 20% glycerol, 20 mM
MOPS, pH 7.0; 10 mM imidazole, PMSF and 10 mM h-
MEt. Membranes were solubilized by addition of 1%
dodecyl h-D-maltoside (DDM) and incubation for 45 min
at 23 jC. Solubilized protein was bound to Ni2 + –NTA
resin (Qiagen) in a batch at 23 jC for another 45 min,
washed three times with Buffer A containing 0.1% DDM,
20 mM imidazole, and 700 mM NaCl, and eluted into 0.3
ml of the same buffer containing 300 mM imidazole and 1
M NaCl. Eluate was precipitated by TCA, re-dissolved in
SDS PAGE loading buffer, and subjected to the SDS PAGE
in 10% polyacrylamide gel. After the electrotransfer onto
Immobilon-P membrane, a major protein band migrating
with an apparent molecular mass close to 54 kDa (calculated
molecular mass of tagged Vc-NhaD is 54.109 kDa) was
excised from the membrane, dried, and used for the direct
N-terminal sequencing (performed in the Protein Micro-
sequencing Laboratory at University of Victoria, British
Columbia).
2.6. Sequence alignments and NhaD topological model
A screen of genomic databases was carried out using the
TBLASTIN program [20]. It confirmed the presence of
highly homologous NhaD-like genes in pathogenic Vibrio
parahaemolyticus [19] and V. cholerae [21]. Their partial
alignments showing the conserved polar residues located
within or associated with putative transmembrane segments
are given in Fig. 1A. Putative membrane topology model of
NhaD from V. cholerae (Fig. 1B) was constructed based on
the Topopredict II [25] and HMMTOP [26] programs.
3. Results
3.1. Determination of the translational start of the Vc-NhaD
gene
Comparison of the derived amino acid sequences of
NhaD from V. cholerae and V. parahaemolyticus reveals
an interesting feature of Vc-NhaD. The first 49 residues of
Vc-NhaD have no homologues in Vp-NhaD, but starting
from Met-50 of Vc-NhaD, both proteins show very high
degree of homology (78% identity and 88% similarity when
aligned by BLASTP 2.0.9 program). We therefore decided
to determine the actual N-terminal sequence of functional
Vc-NhaD. This information is important for the topology
modeling and the selection of target amino acid residues for
site-directed mutagenesis (see the next section). To purify
Vc-NhaD, a 6 histidine tag was added to the C-terminus of
Vc-NhaD as described in Materials and methods. The
resulting plasmid, pBDH, containing the nhaD gene encod-
ing the protein with additional 15 amino acids, 478V-D-K-L-
A-A-A-L-E-H-H-H-H-H-H492, was introduced into the
Na + /H + antiporter-deficient E. coli strain, EP432. Simi-
larly to the EP432/pBLDL transformants (harboring wild-
type variant of NhaD), transformant cells of EP432/pBDH,
but not parental EP432 cells, were able to grow in LBK
medium in the presence of 0.1 M LiCl (data not shown).
Inside-out membrane vesicles of EP432/pBDH demonstra-
ted both Na + /H + and Li + /H + antiport activity (not
shown), further confirming both proper targeting and active
functional state of the tagged antiporter. We were able to
purify tagged Vc-NhaD expressed from its own promoter in
a single step using the Ni2 + chelation chromatography to
produce a major band with an apparent molecular mass of
54 kDa (data not shown). Since the calculated molecular
mass of tagged Vc-NhaD is 54,109 Da if the protein starts
with Met-1 rather than Met-50, the electrophoretical mobi-
lity indicated that mature protein expressed in E. coli
contained an additional N-terminal segment absent in Vp-
NhaD. This was further confirmed by the results of direct N-
terminal sequencing of tagged Vc-NhaD, which gave the
1M-T-G-R-I-A-L-L-S-L-T-L-F13 sequence for the first 13
amino acids of the protein.
3.2. Selection of targets for site-directed mutagenesis
Acidic amino acid residues located within or associated
with transmembrane segments (TMSs) of antiporter pro-
teins are natural candidates for the binding and transfer of
alkali cations, which, if replaced by an aliphatic groups,
will inactivate the antiport. In the absence of experimental
data about membrane topology, the only way of predicting
the putative TMSs is computer modeling, and a probable
membrane topology of Vc-NhaD derived using the
HMMTOP program [26] is shown in Fig. 1A. Another
popular program, Topopredict II [25], yielded a very
similar model. According to the model, Vc-NhaD has 13
TMSs, varying from 17 to 24 residues in length. Appli-
cation of the HMMTOP program to Vp-NhaD resulted in
a model with 11 TMSs. Combining topological models of
Vc-NhaD and Vp-NhaD with their sequence alignment,
one can identify negative residues that are located within
or near the putative transmembrane segments. Only two
intramembrane acidic residues, E100 and D393, are con-
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served in both Vp-NhaD and Vc-NhaD (Fig. 1B). How-
ever, TMS IX of Vc-NhaD has the conserved polar T345
preceded by the conserved acidic D344, which is located
at the membrane–cytoplasm interface (Fig. 1A), a peculiar
‘‘border’’ location that is conserved in both antiporters. In
both cases, another conserved acidic residue (E342 in the
case of Vc-NhaD) is located in a long cytoplasmic loop
close to the DT-harboring TMS (Fig. 1A,B). The position
of E97 in Vc-NhaD is ambivalent: it belongs to the TMS
III in Vc-NhaD, but its counterpart in Vp-NhaD is located
at the membrane–cytoplasm interface. Similarly, D154 of
Vc-NhaD is at the membrane–periplasm interface of the
TMS V in Vc-NhaD, but its analog (D98) in Vp-NhaD is
located in the middle of the putative TMS III. In this
work, we restrict our analysis to residues which are
predicted to have the same location in both antiporters:
E100 and D393 (intramembrane), D344-T345 pair (mem-
brane–cytoplasm interface), E342 (cytoplasm, near DT
pair). For the control, E251 has been chosen (presumably
located in the middle of a cytoplasmic loop in both
proteins). All these residues were replaced by alanine to
study their role in the antiport.
3.3. Effect of Glu100Ala, Glu251Ala, Glu342Ala, Asp344Ala,
Asp393Ala, and Thr345Ala mutations on bacterial growth
The Vc-NhaD variants were expressed in EP432, the
Na + /H + antiporter-deficient strain of E. coli, to assess their
effect on growth (Fig. 2). The pBLDL plasmid used for
transformation [18] allowed the expression of the wild-type
or mutated antiporter from natural nhaD promoter. Being
devoid of ‘‘domestic’’ Na + /H + antiporters, EP432 cells are
highly sensitive to both Na + and Li + ions (Fig. 2A), and
transformation of EP432 with the wild-type Vc-NhaD
restored the ability to grow in the presence of 0.3 M NaCl
and 0.1 M LiCl over the pH range 4.5 to 8.0 (Fig. 2B).
Glu100Ala, Glu251Ala, Glu342Ala, and Asp393Ala variants
also supported growth of EP432 transformants in the
presence of Na + or Li + (Asp393Ala is shown in Fig. 2C
as an example). By contrast, the Asp344Ala and Thr345Ala
variants did not support growth (Thr345Ala is shown in Fig.
2D as an example). Thus, only mutation of Asp344 and of its
closest neighbor, Thr345, altered the Vc-NhaD activity
sufficiently to affect the resistance of EP432 transformants
to sodium and lithium.
Fig. 2. Effect of mutations on the growth of EP432 transformants. Aerobic growth for 7 h in different media was assessed as described in the text. Panel A:
Negative control. EP432 cells were transformed with ‘‘empty’’ pBluescript vector. Panel B: EP432 cells transformed with pBLDL plasmid encoding
nonmutated Vc-NhaD. Panel C: EP432 cells transformed with the Asp393Ala Vc-NhaD. Substitutions Glu100Ala, Glu251Ala, and Glu342Ala gave similar results
(not shown). Panel D: EP432 cells transformed with the Thr345Ala Vc-NhaD. The Asp344Ala mutant had similar growth properties (data not shown).
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3.4. Asp344Ala and Thr345Ala mutations result in inactiva-
tion of the cation/proton antiport
To characterize the effect of Asp344Ala and Thr345Ala
variants on the activity of NhaD directly, we measured Na + /
H + and Li + /H + antiport activities in inside-out membrane
vesicles prepared from corresponding EP432 transformants.
Addition of 10 mM NaCl or LiCl to vesicles prepared from
EP432 cells transformed with wild-type Vc-NhaD led to
partial dissipation of respiration-induced DpH at pH 7.25,
7.75, and 8.5 due to the cation/proton antiport. By contrast,
membranes containing Asp344Ala and Thr345Ala variants of
NhaD showed no Na + /H + or Li + /H + antiport activity at
any pH tested (Fig. 3B,D). The Asp393Ala variant of NhaD
was active at pH 8.5, however at pH 7.75 the activity was
barely detectable (Fig. 3C), indicating a shift in the pH-
profile of its activity toward more alkaline pH.
Indeed, pH-profiles of the activity of Glu100Ala,
Glu251Ala, Glu342Ala, and Asp393Ala variants (Fig. 4)
revealed activities slightly lower than the wild type and
shifted toward alkaline pHs by 0.25–0.5 pH unit. Variant
Asp393Ala has the distinctive property of a pH profile
shifted by more than 1.5 pH units toward alkaline pH
(Fig. 4). This variant was most active at pH 9.5. At pH
higher than 9.5, vesicles showed rather weak response on
the addition of respiratory substrates, impeding quantitation
of the antiport activity. In any of these four mutants, the pH-
profiles of Li + /H + and Na + /H + antiport activity were
nearly identical as is the case for wild-type antiporter (data
not shown). Therefore, these mutations do not change the
cation selectivity of Vc-NhaD, and the observed changes in
pH-profiles of activity do not abolish the ability of the Vc-
NhaD variants to support the growth of EP432 transform-
ants in the presence of Na + and Li + ions (even in the
Asp393Ala mutant, see Fig. 2C).
3.5. Further examination of Asp344 and Asp393 residues
Asp344 and Asp393 residues were chosen for further
study, largely because of the results just described. Asp393
was also chosen because of its apparent analogy with Asp133
Fig. 3. Na + /H + and Li + /H + antiport activities in the inside-out membrane
vesicles from Vc-NhaD mutants. Membrane vesicles were prepared from
EP432 cells carrying the wild-type (A, positive control) or a mutant (B–D)
nhaD expression plasmid, and assayed as described in Materials and
methods. Data shown represent typical result of one of at least three
independent experiments. First arrow at each trek indicates the addition of
lactate. Second arrow indicates the addition of 10 mM NaCl or LiCl. The
upper and bottom panels show Na + /H + and Li + /H + antiport activity,
respectively. pH of the experimental mixture is given at each trek. See text
for further details.
Fig. 4. pH profiles of Na + /H + antiport activity in Vc-NhaD mutants.
Activities were measured as in previous figure and expressed as percent
restoration of the lactate-induced fluorescence quenching. Each point
represents an average of two independent measurements. pH profiles of
Li + /H + antiport in each mutant were nearly identical to those of Na + /H +
antiport (not shown).
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of Ec-NhaA, where intramembrane Asp rather than Glu
residues were indispensable for activity [3,14,15]. Indeed,
the Asp133Ala variant of Ec-NhaA was partially active [15]
much like Asp393Ala in Vc-NhaD, while the Asp133Asn
variant showed no cation/proton antiport activity [14]. In
addition, the Asp393Ala variant of Vc-NhaD resulted in the
largest shift of the pH profile of activity (Fig. 4), implying
the prominent influence of this residue on the activity.
Replacement of Asp344 with Glu resulted in a partially
active protein (Fig. 5B) whereas the Asp344Asn mutation
inactivated the antiport (Fig. 5A), confirming the impor-
tance of the negatively charged side chain. As in Ec-NhaA,
the Asp393Asn variant of Vc-NhaD was unable to catalyze
the cation/proton antiport (Fig. 5C), as was the Asp393Glu
variant (Fig. 5D).
4. Discussion
The major finding of this work is that the two conserved
adjacent polar residues, Asp344 and Thr345, are critical for the
function of Vc-NhaD with both Ala substitutions abolishing
antiport (Fig. 3B,D). Replacement of Asp344 by Asn led to
the same effect (Fig. 5A). In contrast, introduction of another
acidic residue, Glu, instead of Asp344 yielded partially active
antiporter (Fig. 5B). Therefore, a carboxyl group in the
position 344 and hydroxyl in the position 345 seem to be
mandatory for function. In both bacterial [3,14,15,27] and
yeast [16,17] Na + /H + antiporters, conserved intramem-
brane Asp residues have been found to be essential for
activity, presumably forming the cation-binding site
[14,15]. However, the involvement of Thr345 in the case of
Vc-NhaD is intriguing. To the best of our knowledge, this is
the first example of Thr residue being indispensable for Na + /
H + antiport. Our mutagenesis was already completed when
Galili et al. [28] reported that the mutation of the Ec-NhaA
Thr132 (adjacent to the functionally significant Asp133) into
Cys does not abolish the cation–proton exchange completely
but dramatically changes the apparent Km of the antiporter.
The authors mutagenized Thr132 based on the analogy with
bacterial Na + -ATPase where neighboring acidic and
hydroxyl-containing residues are believed to form the cat-
ion-binding site [24]. Indeed, it is very tempting to speculate
that the putative cation-binding site of Vc-NhaD may be
formed by Asp344 and Thr345 in a manner similar to the
subunit c of the Na + (Li + ,H + )–motive ATPase of P. mod-
estum, where the pair of adjacent residues with carboxyl and
hydroxyl groups is clearly involved in the binding of trans-
located cations [23,24]. However, it should be stressed here
that the measurements of fluorescence dequenching give
information about the entire catalytic cycle of the antiporter
but not about its partial reactions such as recognition/binding
of alkaline cations, their translocation, and coupling to the
oppositely directed proton movement. Therefore, it is not
clear at the moment whether Asp344 and Thr345 of Vc-NhaD
are directly involved in alkali cation binding or are essential
for the conformational changes occurring during other steps
of the catalytic cycle, e.g., cation translocation.
Our mutational analysis of Vc-NhaD revealed that four of
five conserved acidic amino acid residues, which are pre-
sumably associated with transmembrane segments, are dis-
pensable for antiporter activity. Mutations Glu100Ala,
Glu251Ala, Glu342Ala, and Asp393Ala did not either arrest
the activity of the antiporter or change the cation specificity
but did shift its pH-profile toward more alkaline pH (Fig. 4).
Since the Asp393Ala variant retains some activity (Fig. 3C),
Asp393 obviously is not indispensable for function, in con-
trast to Asp344 or Thr345. However, the Asp393Asn and
Asp393Glu variants are unable to catalyze cation/proton
antiport (Fig. 5C,D). This, to some extent, resembles the
Asp133 residue in Ec-NhaA [3,14,15]. In both antiporters,
mutation of the corresponding Asp into Asn (but not into
Ala) abolishes Na + /H + antiport completely. It is noteworthy
Fig. 5. Na + /H + and Li + /H + antiport in the membrane vesicles from
Asp344Asn, Asp344Glu, Asp393Asn, and Asp393Glu mutants; all exper-
imental conditions as in Fig. 3. Note that only Asp344Glu mutant showed
measurable antiport activities.
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that although the Asp393Ala variant showed no significant
activity at pH below 8.0 when assayed in inside-out vesicles
(Fig. 4), it nevertheless supported growth in the presence of
Na + or Li + at much lower external pH (Fig. 2C). The most
probable reason for such apparent discrepancy is that the
activity of the Asp393Ala variant below pH 8.0 is too low to
be measured in vesicles in the fluorescence dequenching
assay, but is sufficient for supporting growth. The similar
situation was recently reported and the same explanation
suggested for the A127V variant of Ec-NhaD, which sup-
ports the growth of the EP432 transformants in the presence
of Na + at pH 8.3 but shows no measurable activity when
assayed in everted membrane vesicles at this pH [28].
Further experiments are needed to elucidate mechanism
of Na + /H + exchange catalyzed by Vc-NhaD. Detailed in-
depth analysis, including the measurement of downhill Na +
transport and counterflow experiments, is required to clarify
the role of Asp344, Thr345 and Asp393. It should be men-
tioned also that the topological model of Vc-NhaD pre-
sented here (Fig. 1A) still is a hypothetical one. We plan to
examine the topological structure of Vc-NhaD and its
mechanistic aspects in our future works.
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